Exclusive Licensing Agreement Secured By This Global Healthcare Company

MIRA Pharmaceuticals Secures Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2: What it Means for You.

In an exciting development for the pharmaceutical industry and potentially life-changing news for patients worldwide, MIRA Pharmaceuticals, a leading biopharmaceutical company, has announced an exclusive licensing agreement for Ketamir-2, an oral ketamine analog. This announcement is a milestone moment in the quest for effective treatment options for va…